Treatment of early syphilis with azithromycin (CROSBI ID 546608)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Gruber, Franjo ; Kaštelan, Marija ; Čabrijan, Leo ; Simonić, Edita ; Brajac, Ines
engleski
Treatment of early syphilis with azithromycin
An open, noncomparative study was performed to establish the efficacy of azithromycin in the treatment of early syphilis. Sixteen patients were treated with oral azithromycin: 1g the first day and then 500 mg for the following 8 days. Two patients were excluded from the study, leaving 14 patients for the evaluation of the efficacy. Venereal Disease Research Laboratory (VDRL) negativity was observed in 3 out of 6 patients treated for primary syphilis after 3 months and in all patients after 6 months. Two of 8 patients treated for manifest or early latent secondary syphilis had VDRL negativity after 3 months and 4 patients after 6 months. This study demonstrates that azithromycin is effective in the treatment of early syphilis. Two patients experienced gastrointestinal side effects which did not require treatment interruption.
treatment; syphilis; azithromycin
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
2000.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Podaci o skupu
9th Congress of the European Academy of Dermatology and Venereology
poster
11.10.2000-15.10.2000
Ženeva, Švicarska